ALMO.TA - Algomizer Ltd

Tel Aviv - Tel Aviv Delayed Price. Currency in ILA
140.80
+4.40 (+3.23%)
At close: 5:24PM IDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close136.40
Open138.50
Bid143.80 x 7100
Ask144.90 x 36800
Day's Range137.00 - 146.00
52 Week Range116.10 - 400.70
Volume49,664
Avg. Volume60,537
Market Cap37.17M
Beta (5Y Monthly)0.63
PE Ratio (TTM)N/A
EPS (TTM)-1.39
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateSep 26, 2005
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • GlobeNewswire

      VIRTUAL CRYPTO COMPLETES ACQUISITION OF VIEWBIX

      Viewbix Inc. (the “Company”) today announced the completion of a transaction whereby Virtual Crypto Technologies Inc. (VRCP) (“Virtual Crypto”), developer of software and hardware for the crypto-currency sector, and Algomizer Ltd. (ALMO.TA), consummated a share exchange in which Virtual Crypto acquired Viewbix Ltd. (“Viewbix”). Immediately upon closing of the transaction, Virtual Crypto changed its name to Viewbix Inc. and modified its trading ticker to VBIX.

    • GlobeNewswire

      Medigus to Invest $5 Million in Algomizer Group

      Medigus Ltd. (MDGS) (MDGS.TA), a technology company developing minimally invasive tools and an innovator in direct visualization technology, announced today the signing of a definitive agreement with Algomizer Ltd. (ALMO.TA) and its wholly-owned subsidiary Linkury Ltd. for an investment of approximately $5 million in Algomizer group. The investment is subject to certain pre-conditions to be met no later than September 30, 2019, including the approval of Medigus’ shareholders for an increase of the authorized share capital of Medigus, and other approvals of Algomizer’s shareholders and creditors.